Efficacy of F-18-2-fluoro-2-deoxy-D-glucose Positron Emission Tomography/Computerized Tomography for Bone Marrow Infiltration Assessment in the Initial Staging of Lymphoma

Oner A. O., Budak E. S., AYDIN F., SALİM O., Yucel O. K., AKKAYA B., ...Daha Fazla

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, cilt.26, sa.2, ss.69-75, 2017 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 2
  • Basım Tarihi: 2017
  • Doi Numarası: 10.4274/mirt.54376
  • Dergi Adı: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.69-75
  • Anahtar Kelimeler: Hodgkin's lymphoma, non-Hodgkin's lymphoma, positron emission tomography/computerized tomography, bone marrow biopsy, NON-HODGKINS-LYMPHOMA, F-18-FDG PET/CT, AGGRESSIVE LYMPHOMA, MALIGNANT-LYMPHOMA, CELL LYMPHOMA, FDG-PET/CT, INVOLVEMENT, BIOPSY, DISEASE, MANAGEMENT
  • Marmara Üniversitesi Adresli: Evet

Özet

Objective: Currently F-18-2-fluoro-2-deoxy-D-glucose (F-18-FDG) positron emission tomography/computerized tomography (PET/CT) is being successfully used for staging and follow-up of Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL). Various studies have demonstrated that PET/CT effectively detects bone marrow involvement (BMI) and is concordant with bone marrow biopsy (BMB) findings, thus it is deemed as a complementary method. This study was aimed to evaluate-F-18-FDG-PET/CT efficiency for detection of BMI in HL and NHL.